Literature DB >> 27413715

Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer.

Fergus Macbeth1, Ben Carter1, Simon Noble1, Kerenza Hood1.   

Abstract

Entities:  

Year:  2016        PMID： 27413715      PMCID： PMC4931121          DOI： 10.21037/tlcr.2016.05.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  3 in total

1.  Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.

Authors:  B Lebeau; C Chastang; J M Brechot; F Capron; B Dautzenberg; C Delaisements; M Mornet; J Brun; J P Hurdebourcq; E Lemarie
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

2.  A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Authors:  M Altinbas; H S Coskun; O Er; M Ozkan; B Eser; A Unal; M Cetin; S Soyuer
Journal:  J Thromb Haemost       Date:  2004-08       Impact factor: 5.824

3.  Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.

Authors:  Fergus Macbeth; Simon Noble; Jessica Evans; Sheikh Ahmed; David Cohen; Kerenza Hood; Dana Knoyle; Seamus Linnane; Mirella Longo; Barbara Moore; Penella J Woll; Wiebke Appel; Jeanette Dickson; David Ferry; Caroline Brammer; Gareth Griffiths
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544
  3 in total
  1 in total

1.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Anne Ws Rutjes; Ettore Porreca; Matteo Candeloro; Emanuele Valeriani; Marcello Di Nisio
Journal:  Cochrane Database Syst Rev       Date:  2020-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.